Skip to main content
. 2024 Dec 20;15:533–547. doi: 10.2147/JBM.S493313

Table 1.

Baseline Characteristics of AF Patients (N=114)

Parameter Overall Sample (n=114)
Frequency (n) Percentage (%)
Gender
Female 65 57
Male 49 43
Age group of patients
Age, years, Mean (SD) 66.84 (12.3)
18 to 64 43 37.7
65 to 74 38 33.3
≥75 33 28.9
Highest education level
No formal Education 85 74.6
Below SLC 20 17.5
SLC and above 9 7.9
Duration since AF diagnosis
Less than 2 years 46 40.4
More than 2 years 68 59.6
Employment status
Employed 7 6.1
Unemployed 107 93.9
Smoking
Yes 3 2.6
No 34 29.8
Ex-smoker 77 67.5
Alcohol
Yes 2 1.8
No 48 42.1
Exdrinker 64 56.1
CHA2DS2VASC RISK
CHA2 DS2 VASC score Mean(SD) 2.58 (1.42)
Low risk (0) 6 5.3
Intermediate risk (1) 24 21.1
High risk (≥2) 84 73.7
HASBLED RISK
HASBLED score Mean (SD) 0.96 (0.775)
Low risk (0) 34 29.8
Moderate risk (1–2) 78 68.4
High risk (≥3) 2 1.8
BMI of patients
Severely underweight (< 16.5 kg/m^2) 3 2.6
Underweight (16.5–18.5 kg/m^2) 6 5.3
Normal weight (18.5 to 24.9 kg/m^2) 58 50.9
Obesity (≥30 kg/m^2) 47 41.2
AF Type
Valvular AF 17 14.9
Non Valvular AF 97 85.1
AF Type
Unknown 94 82.5
Paroxysmal AF 17 14.9
Permanent AF 1 0.9
Persistent AF 2 1.8
Category of drug used
No antithrombotic therapy 4 3.5
OAC therapy 93 81.6
Antiplatelet therapy 17 14.9
Comorbidities
Rheumatic heart Disease 26 22.8
COPD 29 25.4
Acute Kidney Injury 8 7.0
Other comorbidities 63 55.3
Congestive heart failure(Signs/symptoms of heart failure or objective evidence of reduced left ventricular ejection fraction) 35 30.7
Dyslipidemia 4 3.5
Carotid Artery Disease 6 5.3
Hypothyroidism 14 12.3
Hypertension(Resting BP >140/90 mmHg on at least two occasions or current antihypertensive treatment) fraction 45 39.5
Age (65–74 yrs) 38 33.3
Age ≥ 75yrs 33 28.9
Diabetes mellitus(Fasting glucose >125 mg/dL (7 mmol/L) or treatment with oral hypoglycemic agent and/or insulin) 16 14.0
Prior stroke, transient ischemic attack, or Thromboembolism 14 12.3
Stroke 12 10.5
Bleeding history/Predisposition(anemia) 9 7.9
Elderly (>65yr) 71 62.3
Antiplatelet therapy 15 13.2

Abbreviations: AF, atrial fibrillation; CHA2DS2VASC, congestive heart failure, hypertension, age ≥75 years (doubled), diabetes mellitus, prior stroke or transient ischemic attack or thromboembolism (doubled), vascular disease, age 65 to 74 years, sex category; HASBLED, Hypertension, Abnormal renal/liver function, Stroke, Bleeding history or predisposition, Labile international normalized ratio, Elderly (.65 years), Drugs/alcohol concomitantly; BMI, Body Mass Index; OAC, Oral Anticoagulants; COPD, Chronic Obstructive Pulmonary Disease.